Outcome Assessment in Patients Treated With Hyperbaric Oxygen Using OxyVu Tissue Oxygenation Monitoring System
Suspended
- Conditions
- Wounds
- Registration Number
- NCT00768027
- Lead Sponsor
- HyperMed
- Brief Summary
The objective is to define patient eligibility for hyperbaric oxygen therapy and to evaluate wound healing progression using a new hyperspectral imaging technology.
- Detailed Description
The purpose of this clinical study is to define patient eligibility for hyperbaric oxygen therapy (HBOT) and to evaluate wound healing progression during HBOT using a new hyperspectral imaging technology (OxyVu).
Recruitment & Eligibility
- Status
- SUSPENDED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method OxyVu measurements will be compared to transcutaneous oxygen measurements pre and post HBOT Days 1, 7, 14, 21, 4wks, and 2 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
Long Beach Memorial Medical Center
🇺🇸Long Beach, California, United States
Long Beach VA Medical Center
🇺🇸Long Beach, California, United States
Hyperbaric & Wound Care Associates
🇺🇸Milwaukee, Wisconsin, United States